Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials - Top-Institutions - MDSpire

Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials

  • By

  • Bruce A. C. Cree

  • Edward Fox

  • Hans-Peter Hartung

  • Enrique Alvarez

  • Peiqing Qian

  • Sibyl Wray

  • Derrick Robertson

  • Krzysztof Selmaj

  • Daniel Wynn

  • Koby Mok

  • Chris Rowland

  • Karthik Bodhinathan

  • Peter Sportelli

  • Hari P. Miskin

  • Lawrence Steinman

  • April 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Immunology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #5

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Immunology

Original Source(s)

Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials

  • by Bruce A. C. Cree, Edward Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Sibyl Wray, Derrick Robertson, Krzysztof Selmaj, Daniel Wynn, Koby Mok, Chris Rowland, Karthik Bodhinathan, Peter Sportelli, Hari P. Miskin, Lawrence Steinman

  • April 1, 2026

Related Content

Editorial: Diffusion-weighted imaging: advances and implementations in neurology

A Pilot, Single-Arm Feasibility Study of a Multidimensional Behavioural Intervention for Cognitive Fatigability in Multiple Sclerosis: Mental Energy Boost Program

Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model